CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2026	Apr. 30, 2026
Current assets:
Cash and cash equivalents	$ 4,358	$ 4,872
Accounts receivable, net	13,602	13,178
Prepaid expenses and other current assets	1,332	1,169
Total current assets	19,292	19,219
Operating lease right-of-use assets, net	9,675	3,697
Property and equipment, net	3,787	3,526
Other long-term assets	201	212
Goodwill	335	335
Total assets	33,290	26,989
Current liabilities:
Accounts payable	5,632	6,903
Accrued liabilities	2,676	2,592
Current portion of operating lease liabilities	635	1,520
Other current liability	234	79
Deferred revenue	9,552	8,828
Total current liabilities	18,729	19,922
Non-current operating lease liabilities	9,886	2,992
Other non-current liabilities	215	7
Total liabilities	28,830	22,921
Stockholders’ equity:
Common stock, $.001 par value; 200,000,000 shares authorized; 14,038,902 and 14,007,159 shares issued; and 13,918,569 and 13,886,826 outstanding as of July 31, 2026 and April 30, 2026, respectively	14	14
Treasury stock, at cost	(708)	(708)
Additional paid-in capital	86,080	85,700
Accumulated deficit	(81,493)	(81,067)
Total stockholders’ equity attributable to Champions Oncology, Inc.	3,893	3,939
Non-controlling interest	567	129
Total stockholders' equity	4,460	4,068
Total liabilities and stockholders’ equity	$ 33,290	$ 26,989